Sirona Biochem Corp. Stock
Your prediction
Pros and Cons of Sirona Biochem Corp. in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Sirona Biochem Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Sirona Biochem Corp. | - | - | - | - | - | - | - |
| Satellos Bioscience Inc. | -4.410% | -0.500% | -6.132% | -33.667% | -28.929% | 158.442% | - |
| Vaxart Inc. | -0.360% | 21.643% | 2.900% | -38.297% | -49.466% | -67.543% | -94.719% |
| Larimar Therapeutics Inc. | -5.810% | 10.256% | 18.621% | -39.649% | -7.527% | -17.308% | -80.868% |
Comments
News
Dentsply Sirona (XRAY) Q2 Sales Drop 5%
Dentsply Sirona (NASDAQ:XRAY), a major player in dental products and technologies, released its second quarter results on August 7, 2025. The company reported GAAP revenue of $936 million and
